ATE144429T1 - Impfstoff - Google Patents

Impfstoff

Info

Publication number: ATE144429T1
Authority: AT; Austria
Prior art keywords: vaccine; bovine; mdbk; quil; propiolactone
Prior art date: 1988-08-03

Application number

AT89909028T

Other languages

English (en)

Inventor

John Christopher Howard

Limited

Michael Cyril Clarke

John Brownlie

Original Assignee

Grampian Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-03

Filing date

1989-08-03

Publication date

1996-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10641529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE144429(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1989-08-03 Application filed by Grampian Pharm Ltd filed Critical Grampian Pharm Ltd

1996-11-15 Application granted granted Critical

1996-11-15 Publication of ATE144429T1 publication Critical patent/ATE144429T1/de

Links

229960005486 vaccine Drugs 0.000 title abstract 2
241000283690 Bos taurus Species 0.000 abstract 2
206010051511 Viral diarrhoea Diseases 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical group O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 abstract 1
230000000120 cytopathologic effect Effects 0.000 abstract 1
229960000380 propiolactone Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT89909028T 1988-08-03 1989-08-03 Impfstoff ATE144429T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8818415A GB8818415D0 (en)	1988-08-03	1988-08-03	Vaccine

Publications (1)

Publication Number	Publication Date
ATE144429T1 true ATE144429T1 (de)	1996-11-15

Family

ID=10641529

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89909028T ATE144429T1 (de)	1988-08-03	1989-08-03	Impfstoff

Country Status (11)

Country	Link
EP (1)	EP0427767B1 (de)
JP (1)	JP3043353B2 (de)
AT (1)	ATE144429T1 (de)
AU (1)	AU628845B2 (de)
CA (1)	CA1319634C (de)
DE (2)	DE68927380T2 (de)
DK (1)	DK174167B1 (de)
GB (2)	GB8818415D0 (de)
IE (1)	IE77508B1 (de)
NL (1)	NL300073I1 (de)
WO (1)	WO1990001337A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4308092A1 (de) *	1993-03-13	1994-09-29	Behringwerke Ag	Rinderovarzellinie (FROv) zur Virusvermehrung
NZ276234A (en) *	1993-11-05	1998-01-26	Bayer Ag Substituted Under Sec	An attenuated replicating non pathogenic flavivirus (bovine viral diarrhoea virus - bvdv) vaccine
IT1276070B1 (it)	1995-10-31	1997-10-24	Siac It Additivi Carburanti	Processo per la preparazione di polimeri a base di etilene a basso peso molecolare
NZ538394A (en) *	2002-08-26	2008-06-30	Pfizer Prod Inc	Vaccine for respiratory and reproductive system infections in cattles
RU2403063C1 (ru) *	2009-08-28	2010-11-10	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина инактивированная комбинированная против вирусной диареи, рота-, коронавирусной болезней и эшерихиоза крупного рогатого скота

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3293129A (en) *	1962-02-01	1966-12-20	Cornell Res Foundation Inc	Immunization of cattle against virus diarrhea virus
US3839556A (en) *	1969-11-28	1974-10-01	Univ Nebraska	Calf diarrhea virus vaccine and processes
US3838004A (en) *	1970-11-17	1974-09-24	Univ Nebraska	Calf diarrhea virus vaccine and processes
US3869547A (en) *	1971-11-10	1975-03-04	Univ Nebraska	Calf diarrhea virus vaccine and processes
SE419500B (sv) *	1972-10-30	1981-08-10	Univ Nebraska	Forfarande for attenuering av ett koronavirusliknande kalvdiarrevirus for framstellning av kalvdiarrevaccin
SE8205892D0 (sv) *	1982-10-18	1982-10-18	Bror Morein	Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin

1988
- 1988-08-03 GB GB8818415A patent/GB8818415D0/en active Pending
1989
- 1989-08-02 IE IE249589A patent/IE77508B1/en not_active IP Right Cessation
- 1989-08-03 AU AU40491/89A patent/AU628845B2/en not_active Expired
- 1989-08-03 AT AT89909028T patent/ATE144429T1/de not_active IP Right Cessation
- 1989-08-03 WO PCT/GB1989/000882 patent/WO1990001337A1/en not_active Ceased
- 1989-08-03 DE DE68927380T patent/DE68927380T2/de not_active Expired - Lifetime
- 1989-08-03 JP JP50849489A patent/JP3043353B2/ja not_active Expired - Lifetime
- 1989-08-03 DE DE2001199014 patent/DE10199014I2/de active Active
- 1989-08-03 EP EP19890909028 patent/EP0427767B1/de not_active Expired - Lifetime
- 1989-08-03 CA CA 607533 patent/CA1319634C/en not_active Expired - Lifetime
1991
- 1991-01-30 DK DK199100165A patent/DK174167B1/da not_active IP Right Cessation
- 1991-02-01 GB GB9102162A patent/GB2239799B/en not_active Expired - Lifetime
2001
- 2001-11-30 NL NL300073C patent/NL300073I1/nl unknown

Also Published As

Publication number	Publication date
DE68927380T2 (de)	1997-03-27
DK174167B1 (da)	2002-08-05
IE892495L (en)	1990-02-03
DE10199014I1 (de)	2001-06-28
DE68927380D1 (de)	1996-11-28
CA1319634C (en)	1993-06-29
GB8818415D0 (en)	1988-09-07
NL300073I1 (nl)	2002-02-01
EP0427767B1 (de)	1996-10-23
DK16591A (da)	1991-01-30
GB2239799B (en)	1992-01-22
AU628845B2 (en)	1992-09-24
WO1990001337A1 (en)	1990-02-22
GB9102162D0 (en)	1991-04-10
JPH04500069A (ja)	1992-01-09
JP3043353B2 (ja)	2000-05-22
DK16591D0 (da)	1991-01-30
GB2239799A (en)	1991-07-17
DE10199014I2 (de)	2007-12-20
EP0427767A1 (de)	1991-05-22
IE77508B1 (en)	1998-01-14
AU4049189A (en)	1990-03-05

Legal Events

Date	Code	Title
1997-04-15	UEP	Publication of translation of european patent specification
2000-04-15	EEIH	Change in the person of patent owner
2009-11-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
DE69939706D1 (de)	2008-11-20	Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden
LV10203A (lv)	1994-10-20	Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
IE791575L (en)	1980-02-17	Hepatitis a vaccine
DE68924775D1 (de)	1995-12-14	Verwendungen viraler enzyme.
DE10199014I1 (de)	2001-06-28	Impfstoff
DK90090A (da)	1990-04-10	Fremgangsmaade til fremstilling af naturligt hiv gp160
DK8789D0 (da)	1989-01-10	Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
ES2082221T3 (es)	1996-03-16	Neuraminidasa y galactosa-oxidasa en calidad de adyuvante de vacunas.
AU554859B2 (en)	1986-09-04	Polymerized albumin vaccine
AU532186B2 (en)	1983-09-22	Herpes virus vaccine
DK506979A (da)	1980-05-31	Vaccine mod infektioes katte-peritonitis og fremgangsmaade til dens fremstilling
DK0485463T3 (da)	1995-11-27	Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
UA21969A1 (uk)	1998-04-30	Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі
张德礼	1990	SUCCESS IN PREPARING INACTIVATED VACCINES WITH MINERAL OIL OR AI (OH) _3 GEL ADJUVANT FROM SERUMFREE CELL CULTURES OF MINK ENTERITIS VIRUS (MEV)
EP0236058A3 (en)	1989-01-25	Vaccine against herpes simplex
IT1227900B (it)	1991-05-14	Vaccino anti-herpes e relative composizioni farmaceutiche
NO884921L (no)	1990-05-07	Fremgangsmaate for fremstilling av valpesyke-vaksine.
HUT52812A (en)	1990-08-28	Process for production of liofilized vaccina against infective bursitis
KR840001834A (ko)	1984-06-07	감보로 생독 백신의 제조방법